http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102939097-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
| filingDate | 2010-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102939097-B |
| titleOfInvention | For the new synergistic pharmaceutical combination of topical application |
| abstract | New synergistic pharmaceutical combination for the preparation of the topical formulations for preventing and treat wound, burn, skin graft, pressure ulcer and diabetic keratopathy ulcer of foot is disclosed. Described cooperative compositions comprises the short Cyclin with one or more bactericide and bacteriostatic agent combination. Does is short Cyclin in the present invention recombinant human epidermal growth factor (Bharat? Biotech? International? the rh-EGF of Limited) and/or any other growth factor, as rh-PDGF-BB, and bactericide and bacteriostatic agent are broad-spectrum antibiotic flamazine (SSD) and chlorhexidine gluconate (CHG). Except cooperative compositions, topical formulations also comprises substrate composition, carrier, anticorrisive agent, emulsifying agent, emollient and soft skin agent and one or more other components. New compositions produces cooperative effect, silver-colored effect, the antagonism that reverses SSD as wider antibacterial covering, by rh-EGF burn in the effect and better and wound healing faster of silver-colored resistant microorganism. New compositions can be used for the topical formulations for the preparation of emulsifiable paste, gel or liquid form. Novel formulation has the longer shelf life and stablizes and exceed 2 years under the storage temperature of 2-8 DEG C. |
| priorityDate | 2010-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 156.